Bank Of America Corp Sarepta Therapeutics, Inc. Put Options Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $2.69 Million - $4.99 Million	40,000 Added 366.97%	50,900 $4.91 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $7.59 Million - $11.2 Million	-71,300 Reduced 86.74%	10,900 $1.25 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $6.41 Million - $8.5 Million	54,500 Added 196.75%	82,200 $11.3 Million
Q4 2022 Feb 10, 2023	BUY	$100.86 - $132.13 $2.09 Million - $2.74 Million	20,700 Added 295.71%	27,700 $3.59 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $1.45 Million - $2.28 Million	-19,100 Reduced 73.18%	7,000 $774,000
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $1.2 Million - $1.69 Million	19,100 Added 272.86%	26,100 $1.96 Million
Q4 2021 Feb 08, 2022	BUY	$77.28 - $99.42 $540,960 - $695,940	7,000 New	7,000 $630,000

532

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.15B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.